Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06916767 |
Title | Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Substudy B: CLL Patients |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Paolo Caimi, MD |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |